Brief: PharmaSGP Holding H1 Adj. EBITDA Down At EUR 6.5 Mln

PharmaSGP Holding SE

16/09/2021 06:38

Sept 16 (Reuters) - PHARMASGP HOLDING SE  PSGG.DE :
    * H1 REVENUES DECREASED BY 21.8 % TO EUR 26.4 MILLION
(PREVIOUS
YEAR: EUR 33.8 MILLION)
    * H1 ADJUSTED EBITDA AMOUNTED TO EUR 6.5 MILLION (PREVIOUS
YEAR:
EUR 10.9 MILLION)
    * H1 UNADJUSTED EBITDA AMOUNTED TO EUR 5.9 MILLION
    * CONFIRMS INCREASED FORECAST FOR 2021 FINANCIAL YEAR
RELEASED ON
SEPTEMBER 15, 2021
    * FULL YEAR GUIDANCE RAISED ON SEPTEMBER 15, 2021 DUE TO
ACQUISITION: REVENUES BETWEEN EUR 60 MILLION AND EUR 65 MILLION,
ADJUSTED EBITDA MARGIN OF 27-31 %

Source text for Eikon:  ID:nEQ8nBfCa 
Further company coverage:  PSGG.DE 

 (Gdansk Newsroom)
 ((Gdansk.Newsroom@thomsonreuters.com;))